Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU

Biological therapy is a cornerstone in the treatment of pouch disorders, demonstrating consistently high effectiveness. After anti-TNF failure, another mechanism of action should be employed.

Authors

Institutions

Publication Details

Journal
Therapeutic Advances in Gastroenterology
Published
2026-02-18
DOI
https://doi.org/10.1177/17562848261422373
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU

Alejandro Hernández-Camba, Cristina Rubín de Célix, Guillermo Jiménez Bastida, Antonio Maria Caballero-Mateos et al.
Therapeutic Advances in Gastroenterology
Inflammatory Bowel Disease
article

Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU

Alejandro Hernández-Camba, Cristina Rubín de Célix, Guillermo Jiménez Bastida, Antonio Maria Caballero-Mateos, Eduardo Leo Carnerero, José Miranda-Bautista, I Jiménez, B Casís, Federico Bertoletti, Luis Javier Lamuela, Berta Caballol, Laura Ramos, Abdel Bouhmidi, Marta Piqueras, R Baltar, Leyanira Torrealba, A Sobrino, M. Montoro-Huguet, Coral Tejido, Yamile Zabana, María Carmen Rodríguez-Grau, Gerard Surís, A. Albillos, Iria Bastón-Rey, Margalida Calafat, I Rodríguez-Lago, José María Huguet, Alfonso Elosua, Natalia García-Morales, Francisco Mesonero, Irene González-Partida, Miren Vicuña, Eduard Brunet-Mas, Manuel Barreiro-de Acosta, María José García, Luis Sánchez-Guillén, Andrés Castaño, Agnès Fernández-Clotet, Benito Hermida, Rosa María Sáiz-Chumillas, Ingrid Fajardo, Alicia López-García, Rodrigo Nájera, Antonio López-Sanromán, Ramón Pajares, Cristina Suarez Ferrer, Rocío Ferreiro-Iglesias
article en

Abstract

Biological therapy is a cornerstone in the treatment of pouch disorders, demonstrating consistently high effectiveness. After anti-TNF failure, another mechanism of action should be employed.

Therapeutic Advances in GastroenterologyVol. 19
Universidad de Alcalá (ES), Hospital Universitario de Canarias (ES), Hospital Universitario La Paz (ES), Hospital de Sant Pau (ES), Bellvitge University Hospital (ES), University Hospital Complex Of Vigo (ES), Hospital General Universitario Gregorio Marañón (ES), Hospital Universitari i Politècnic La Fe (ES), Hospital Universitario Nuestra Señora de Candelaria (ES), Complejo Hospitalario Universitario de Santiago (ES), Complejo Hospitalario de Navarra (ES), Consorci Sanitari de Terrassa (ES), Hospital Universitario 12 De Octubre (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Hospital Universitario Araba (ES), Instituto de Investigación Marqués de Valdecilla (ES), Hospital Universitario Miguel Servet (ES), Hospital Universitario de Burgos (ES), Hospital General Universitario de Elche (ES), Hospital General Universitario de Ciudad Real (ES), Hospital de Galdakao (ES), Complejo Hospitalario Universitario de Granada (ES), Hospital Universitario Reina Sofía (ES), Hospital General Universitario De Valencia (ES), Mútua Terrassa (ES), Hospital Universitario de La Princesa (ES), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES), Hospital Universitario Central de Asturias (ES), Hospital General Universitario de Alicante Doctor Balmis (ES), Hospital Universitario De Cabueñes (ES), Hospital Universitario del Henares (ES), Hospital Universitario Virgen del Rocío (ES), Hospital Universitari Germans Trias i Pujol (ES), Hospital Universitari de Girona Doctor Josep Trueta (ES), Hospital del Mar Research Institute (ES), Hospital General San Jorge (ES), Hospital Universitario Río Hortega (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Hospital Universitario Infanta Sofía (ES), Hospital Universitario Ramón y Cajal (ES), Complejo Hospitalario de Ourense (ES), Deleted Institution, Universidad Autónoma de Madrid (ES)
Openalex Percentile: Top 48%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.